Estrogen Receptor-α Non-Nuclear Signaling Confers Cardioprotection and Is Essential to cGMP-PDE5 Inhibition Efficacy

Nobuaki Fukuma,Eiki Takimoto,Kazutaka Ueda,Pangyen Liu,Miyu Tajima,Yu Otsu,Taro Kariya,Mutsuo Harada,Haruhiro Toko,Kaori Koga,Robert M Blanton Jr,Richard H Karas,Issei Komuro
DOI: https://doi.org/10.1016/j.jacbts.2019.12.009
2020-03-04
Abstract:Using genetically engineered mice lacking estrogen receptor-α non-nuclear signaling, this study demonstrated that estrogen receptor-α non-nuclear signaling activated myocardial cyclic guanosine monophosphate-dependent protein kinase G and conferred protection against cardiac remodeling induced by pressure overload. This pathway was indispensable to the therapeutic efficacy of cyclic guanosine monophosphate-phosphodiesterase 5 inhibition but not to that of soluble guanylate cyclase stimulation. These results might partially explain the equivocal results of phosphodiesterase 5 inhibitor efficacy and also provide the molecular basis for the advantage of using a soluble guanylate cyclase simulator as a new therapeutic option in post-menopausal women. This study also highlighted the need for female-specific therapeutic strategies for heart failure.
What problem does this paper attempt to address?